Take a trial of UK to unlock this pageFind out more

Relative Strength (%)
Volume Change (%)
10d v 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
Margin of Safety (beta)
Screens Passed
Balance Sheet · Income Statement · Cashflow Financial Summary
Year End 31st Mar 2010 2011 2012 2013 2014 2015 2016E 2017E CAGR / Avg
Revenue £m
Operating Profit £m
Net Profit £m
EPS Reported p
EPS Normalised p
EPS Growth %
PE Ratio x
Operating Margin %
Op. Cashflow ps p
Capex ps p
Free Cashflow ps p
Last ex-div: 23rd Jul, paid: 21st Aug more... Dividends
Dividend ps p
Dividend Growth %
Dividend Yield %
Dividend Cover x
Balance Sheet
Cash etc £m
Working Capital £m
Net Fixed Assets £m
Net Debt £m
Book Value £m
Average Shares m
Book Value ps p +5.2%

FINANCIAL BRIEF: For the fiscal year ended 31 March 2015, Immunodiagnostic Systems Hldgs PLC revenues decreased 13% to L45.4M. Net income decreased 66% to L2.4M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Dividend per share decreased from L0.09 to L0.03. Basic Earnings per Share excluding Extraordinary Items decreased from L0.24 to L0.08. more »

Health Trend
Bankruptcy Risk
  Earnings Manipulation Risk
Magic Formula Score
Other Ratios
Leverage (ttm) Total Ex Intang
Gross Gearing %
Net Gearing %
Cash / Assets %
Recent History
Latest interim period (ended 31st Mar '15) vs. prior year
Sales Growth %
EPS Growth %
3yr Compound Annual Growth Rate
Sales Growth %
EPS Growth %
DPS Growth %

Broker Forecasts
31st Mar 2016
31st Mar 2017

Price Target: 2.86
(+1.31% above Price)
Net Profit EPS DPS Net Profit EPS DPS
Est. Long Term Growth Rate: n/a (£) (p) (p) (£) (p) (p)
Consensus Estimate
1m Change
3m Change
4 brokers Broker Consensus Trend
Broker Recommendations for Immunodiagnostic Systems Holdings
Recommendation:Strong SellSellHoldBuyStrong Buy
No. of Analysts: 1 1 2 0 0

Named Brokers and Analysts
Investec Bank (UK) Plc Nicholas Keher , Canaccord Genuity Julie Simmonds , Panmure Gordon Savvas Neophytou , Peel Hunt Paul Cuddon , Edison Investment Research John Savin , Daniel Stewart , N+1 Singer Elizabeth Klein Chris Glasper , FinnCap ,

Profile Summary

Immunodiagnostic Systems Holdings plc (IDS) is engaged in manufacturing and distributing medical diagnostic products. The Company is also involved in research and development projects. The Company is a supplier of specialist immunoassay kits and automated immune analyzer technologies for use in research, medical and pharmaceutical applications. The company holds strong position in the provision of immunoassay kits for the determination of Vitamin D, that includes; both 25 Hydroxy- and 1,25 Dihydroxy- Vitamin D. The Company is also focused to remain at the forefront of Vitamin D testing globally, and its fully automated Vitamin D test on the IDS-iSYS. The IDS-iSYS automated analyser allows IDS to compete more effectively for the larger accounts in reference laboratories and Clinical Research Organisations, whilst also easing the pressure of growing volumes of testing being experienced by small to mid-sized laboratories.

Directors: Carlos Zando (CEO) 49, Burkhard Wittek (NEC) 60, Till Campe (NED) 24, Peter Williamson (NED) 49, Edward Blair (NID) 54, Roland Sackers (NID) 46,

No. of Employees: 328 No. of Shareholders: n/a

Last Annual March 31st, 2015
Last Interim March 31st, 2015
Shares in Issue 29,195,276
Free Float 20.9m (71.7%)
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index FTSE Intl-aim All Share ,
Exchange London Stock Exchange (AIM)
Eligible for an ISA? a SIPP?

IDH Share Price Performance IDHQuote
0.0  0.0%
Traded 9:52am · Minimum 15 min delayed · NMS: 0.500k

Latest IDH News Announcements (delayed)

Upcoming IDH Events
Thursday 23rd July, 2015
Dividend For IDH.L

Recent ↓
Tuesday 25th November, 2014
Half Year 2014 Immunodiagnostic Systems Holdings PLC Earnings Release
Tuesday 14th October, 2014
Half Year 2014 Immunodiagnostic Systems Holdings PLC Trading Statement Release
Monday 4th August, 2014
Immunodiagnostic Systems Holdings PLC Annual Shareholders Meeting
Monday 4th August, 2014
Immunodiagnostic Systems Holdings PLC Trading Statement
Wednesday 23rd July, 2014
Dividend For IDH.L
Tuesday 24th June, 2014
Full Year 2013 Immunodiagnostic Systems Holdings PLC Earnings Release

Use of our data service is subject to express Terms of Service. Please see our full site disclaimer for more details. In particular, it is very important to do your own research (DYOR) and seek professional advice before making any investment based on your own personal circumstances. Please note that the information, data and analysis contained within this stock report: (a) include the proprietary information of Stockopedia's third party licensors and Stockopedia; (b) should not be copied or redistributed except as specifically authorised; and (c) are not warranted to be complete, accurate or timely. You should independently research and verify any information that you find in this report. Stockopedia will not be liable in respect of any loss, trading or otherwise, that you may suffer arising out of such information or any reliance you may place upon it. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up. © Stockopedia 2015.

Should you buy IDH

Access IDH Analytics Now!

Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis